RNA sequencing of non-targetting ASOs on HEK293 and U2OS cells
RNA-seq (gene expression) · human · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 36 samples: 9 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- A CRISPR/Cas9 screen reveals proteins at the endosome-Golgi interface that modulate cellular anti-sense oligonucleotide activityNature communications · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE280432_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1178585 and SRA study SRP541548. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 36 samples.
How we read this: 9 replicated groups read from 36 sample titles; they account for 36 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8597815 U2OS-CTRL1 ASO-3 days-rep1 U2OS-CTRL1 ASO-3 days
- GSM8597816 U2OS-CTRL1 ASO-3 days-rep2 U2OS-CTRL1 ASO-3 days
- GSM8597817 U2OS-CTRL1 ASO-3 days-rep3 U2OS-CTRL1 ASO-3 days
- GSM8597818 U2OS-CTRL1 ASO-3 days-rep4 U2OS-CTRL1 ASO-3 days
- GSM8597819 U2OS-CTRL2 ASO-3 days-rep1 U2OS-CTRL2 ASO-3 days
- GSM8597820 U2OS-CTRL2 ASO-3 days-rep2 U2OS-CTRL2 ASO-3 days
- GSM8597821 U2OS-CTRL2 ASO-3 days-rep3 U2OS-CTRL2 ASO-3 days
- GSM8597822 U2OS-CTRL2 ASO-3 days-rep4 U2OS-CTRL2 ASO-3 days
- GSM8597823 U2OS-CTRL3 ASO-3 days-rep1 U2OS-CTRL3 ASO-3 days
- GSM8597824 U2OS-CTRL3 ASO-3 days-rep2 U2OS-CTRL3 ASO-3 days
- GSM8597825 U2OS-CTRL3 ASO-3 days-rep3 U2OS-CTRL3 ASO-3 days
- GSM8597826 U2OS-CTRL3 ASO-3 days-rep4 U2OS-CTRL3 ASO-3 days
- GSM8597827 U2OS-SSO-3 days-rep1 U2OS-SSO-3 days
- GSM8597828 U2OS-SSO-3 days-rep2 U2OS-SSO-3 days
- GSM8597829 U2OS-SSO-3 days-rep3 U2OS-SSO-3 days
- GSM8597830 U2OS-SSO-3 days-rep4 U2OS-SSO-3 days
- GSM8597831 U2OS-untreated-rep1 U2OS-untreated
- GSM8597832 U2OS-untreated-rep2 U2OS-untreated
- GSM8597833 U2OS-untreated-rep3 U2OS-untreated
- GSM8597834 U2OS-untreated-rep4 U2OS-untreated
- GSM8597835 HEK293-CTRL1 ASO-3 days-rep1 HEK293-CTRL1 ASO-3 days
- GSM8597836 HEK293-CTRL1 ASO-3 days-rep2 HEK293-CTRL1 ASO-3 days
- GSM8597837 HEK293-CTRL1 ASO-3 days-rep3 HEK293-CTRL1 ASO-3 days
- GSM8597838 HEK293-CTRL1 ASO-3 days-rep4 HEK293-CTRL1 ASO-3 days
- GSM8597839 HEK293-CTRL2 ASO-3 days-rep1 HEK293-CTRL2 ASO-3 days
- GSM8597840 HEK293-CTRL2 ASO-3 days-rep2 HEK293-CTRL2 ASO-3 days
- GSM8597841 HEK293-CTRL2 ASO-3 days-rep3 HEK293-CTRL2 ASO-3 days
- GSM8597842 HEK293-CTRL2 ASO-3 days-rep4 HEK293-CTRL2 ASO-3 days
- GSM8597843 HEK293-CTRL3 ASO-3 days-rep1 HEK293-CTRL3 ASO-3 days
- GSM8597844 HEK293-CTRL3 ASO-3 days-rep2 HEK293-CTRL3 ASO-3 days
- GSM8597845 HEK293-CTRL3 ASO-3 days-rep3 HEK293-CTRL3 ASO-3 days
- GSM8597846 HEK293-CTRL3 ASO-3 days-rep4 HEK293-CTRL3 ASO-3 days
- GSM8597847 HEK293-untreated-rep1 HEK293-untreated
- GSM8597848 HEK293-untreated-rep2 HEK293-untreated
- GSM8597849 HEK293-untreated-rep3 HEK293-untreated
- GSM8597850 HEK293-untreated-rep4 HEK293-untreated
- GSE280430 RNA sequencing of AP1M1 KO HEK293 and U2OS 32 samples shares hek293, u2os
- GSE317890 Transcriptomic profiling of interferon responses induced by IVT sgRNAs in CRISPRi HEK293T cells 360 samples shares hek293
- GSE87198 RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 17 samples shares hek293
- GSE246377 RNA Sequencing of HEK293T cells expressing 15xGly or 99xGly 12 samples shares hek293
- GSE252809 RNA Sequencing Reveals Transcriptomic Changes in HEK293 Cells Following Introduction of rs16851030 DNA Variant 6 samples shares hek293
- GSE315903 Temporal dynamics and functional annotation of transcriptome rhythmicity in HEK293T cells 39 samples shares hek293
- GSE335700 RNA sequencing of vtRNA-knockout HEK293T cell lines 36 samples shares hek293
- GSE288118 An arrayed CRISPR screen identifies knockout combinations improving antibody productivity in HEK293 cells 28 samples shares hek293
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.